Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Capsid
65%
Amino Terminal Sequence
54%
Interferon Type I
37%
Adenovirus Vaccine
37%
Humoral Immunity
37%
Adenovirus Vector
34%
Nuclear Import
31%
Oligomerization
29%
Innate Immune System
25%
Nuclear Pore Complex
25%
Target Organism
25%
Human Adenovirus E
25%
Serine
25%
Experimental Animal
25%
Serotype
25%
Adaptive Immune System
25%
Transgene
25%
Severe Acute Respiratory Syndrome Coronavirus 2
25%
Orthomyxoviridae
22%
Antiviral Activity
20%
Nuclear Pore
18%
Myosin
18%
Light Chain
18%
Adoptive Immunity
17%
Adenoviridae
15%
Arginine
12%
Nucleocytoplasmic Transport
12%
Cytotoxic T-Cell
12%
Human Adenovirus C
12%
Spike
10%
Immunoprecipitation
9%
Interferon-Stimulated Gene
9%
T-Helper Cell
6%
Cell Line
6%
RNA Interference
6%
Phenylalanine
6%
Virus Inhibition
6%
Yeast Two-Hybrid Screening
6%
Fluorescence Microscopy
6%
Dephosphorylation
6%
Cell Function
6%
Cytokine
6%
Influenzavirus A
5%
Covalent Bond
5%
Receptor Binding
5%
Titer
5%
Neutralization
5%
COVID-19
5%
Neutralizing Antibody
5%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus 1
75%
N-Terminus
52%
Capsid
37%
Nuclear Import
31%
Interferon
29%
Isoform
25%
Target Organism
25%
Serine
25%
Innate Immunity
25%
GTPase
25%
Transgene
25%
Human Adenovirus E
25%
Adenovirus Vector
25%
Serotype
25%
Experimental Animal
25%
Adaptive Immunity
25%
Nuclear Pore Complex
25%
(Myosin-Light-Chain) Phosphatase
18%
T Cell
18%
Nuclear Membrane
18%
Nuclear Pore
18%
Nucleoporin
18%
Orthomyxoviridae
16%
Nuclear Transport
12%
Adaptive Response
12%
Humoral Immunity
12%
Adenoviridae
12%
Human Adenovirus C
12%
Cellular Immunity
12%
CD8
12%
Animal Models
12%
Arginine
12%
Antiviral Activity
12%
Interferon-Stimulated Gene
6%
Dephosphorylation
6%
Cytokine
6%
Cell Function
6%
Transport Receptor
6%
RNA Interference
6%
Virus Inhibition
6%
Fluorescence Microscopy
6%
CD4
6%
Immunoprecipitation
6%
Yeast Two-Hybrid Screening
6%
Phenylalanine
6%
Medicine and Dentistry
Humoral Immunity
25%
Adenovirus Vaccine
25%
Severe Acute Respiratory Syndrome Coronavirus 2
25%
Virus Capsid
25%
Adenoviridae
15%
Adenovirus Vector
10%
Virus Particle
5%
COVID-19
5%
Incubation
5%
Antibody Response
5%
Neutralizing Antibody
5%
Covalent Bond
5%
Receptor Binding
5%
T Cell
5%
Neutralization
5%
Cellular Immunity
5%
Immunogenicity
5%
Infection
5%